About
Digistain develops clinical diagnostic technology utilizing infrared spectroscopy to analyze tissue chemistry for objective assessment of cancer pathology and prediction of treatment response in hospitals and pathology labs.
Explore Digistain's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.